Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
Volume 44, Issue 9, Pages 495-501
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-07-16
DOI
10.1097/coc.0000000000000849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
- (2020) Sarah B Goldberg et al. LANCET ONCOLOGY
- Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors
- (2019) Lizza E.L. Hendriks et al. Journal of Thoracic Oncology
- Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients
- (2019) Guillaume Klausner et al. Clinical Genitourinary Cancer
- Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non–small cell lung cancer with brain metastases
- (2019) Charu Singh et al. JOURNAL OF NEUROSURGERY
- Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
- (2019) Giuseppe Minniti et al. Journal for ImmunoTherapy of Cancer
- Brain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and Heterogeneous
- (2019) Jarred P. Reed et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
- (2019) Ronan Flippot et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non–small cell lung cancer to the brain: a matched cohort study
- (2019) Matthew J. Shepard et al. JOURNAL OF NEUROSURGERY
- Brain Metastasis From Renal-Cell Carcinoma: An Institutional Study
- (2019) Alfredo Suarez-Sarmiento et al. Clinical Genitourinary Cancer
- Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
- (2019) Robert J Motzer et al. LANCET ONCOLOGY
- Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
- (2018) Linda Chen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
- (2018) Georgina V Long et al. LANCET ONCOLOGY
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
- (2018) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data
- (2018) Eric J. Lehrer et al. RADIOTHERAPY AND ONCOLOGY
- Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
- (2017) Daniel N Cagney et al. NEURO-ONCOLOGY
- Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation
- (2017) Luke R.G. Pike et al. RADIOTHERAPY AND ONCOLOGY
- Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control
- (2017) Yi An et al. RADIOTHERAPY AND ONCOLOGY
- Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery
- (2016) Jack M. Qian et al. CANCER
- Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
- (2016) Paul D. Brown et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery
- (2013) Andrew M. Baschnagel et al. JOURNAL OF NEUROSURGERY
- Predictors of Survival in Contemporary Practice After Initial Radiosurgery for Brain Metastases
- (2012) Anna Likhacheva et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Comprehensive Review of MR Imaging Changes following Radiosurgery to 500 Brain Metastases
- (2011) T.R. Patel et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
- (2011) M. Bianchi et al. ANNALS OF ONCOLOGY
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started